ARVN
Price
$8.27
Change
+$0.52 (+6.71%)
Updated
Sep 26 closing price
Capitalization
607.16M
44 days until earnings call
TRML
Price
$47.74
Change
+$0.02 (+0.04%)
Updated
Sep 26 closing price
Capitalization
1.23B
Interact to see
Advertisement

ARVN vs TRML

Header iconARVN vs TRML Comparison
Open Charts ARVN vs TRMLBanner chart's image
Arvinas
Price$8.27
Change+$0.52 (+6.71%)
Volume$3.04M
Capitalization607.16M
Tourmaline Bio
Price$47.74
Change+$0.02 (+0.04%)
Volume$963.52K
Capitalization1.23B
ARVN vs TRML Comparison Chart in %
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. TRML commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Buy and TRML is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (ARVN: $8.27 vs. TRML: $47.74)
Brand notoriety: ARVN and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 159% vs. TRML: 98%
Market capitalization -- ARVN: $607.16M vs. TRML: $1.23B
ARVN [@Biotechnology] is valued at $607.16M. TRML’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 0 green, 5 red.
According to our system of comparison, TRML is a better buy in the long-term than ARVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 7 TA indicator(s) are bullish while TRML’s TA Score has 3 bullish TA indicator(s).

  • ARVN’s TA Score: 7 bullish, 3 bearish.
  • TRML’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than TRML.

Price Growth

ARVN (@Biotechnology) experienced а +9.97% price change this week, while TRML (@Biotechnology) price change was +0.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($1.23B) has a higher market cap than ARVN($607M). TRML YTD gains are higher at: 135.404 vs. ARVN (-56.860). TRML has higher annual earnings (EBITDA): -102.41M vs. ARVN (-112.6M). ARVN has more cash in the bank: 861M vs. TRML (239M). TRML has less debt than ARVN: TRML (145K) vs ARVN (9.9M). ARVN has higher revenues than TRML: ARVN (373M) vs TRML (0).
ARVNTRMLARVN / TRML
Capitalization607M1.23B49%
EBITDA-112.6M-102.41M110%
Gain YTD-56.860135.404-42%
P/E RatioN/AN/A-
Revenue373M0-
Total Cash861M239M360%
Total Debt9.9M145K6,828%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNTRML
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 7 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VQSRX25.160.18
+0.72%
Virtus KAR Small-Cap Value R6
MWEBX40.760.27
+0.67%
MFS Global Equity B
TGREX12.430.08
+0.65%
TCW Global Real Estate I
FFIMX22.520.07
+0.31%
Fidelity Advisor Asset Manager 50% I
DNMDX29.15N/A
N/A
Dunham Monthly Distribution N

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ERAS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
+6.71%
ERAS - ARVN
39%
Loosely correlated
+14.92%
GMAB - ARVN
37%
Loosely correlated
+0.80%
TECH - ARVN
36%
Loosely correlated
+2.71%
TRML - ARVN
35%
Loosely correlated
+0.04%
COGT - ARVN
34%
Loosely correlated
+6.55%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been loosely correlated with DNTH. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TRML jumps, then DNTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+0.04%
DNTH - TRML
42%
Loosely correlated
+2.43%
STOK - TRML
37%
Loosely correlated
+5.19%
ARVN - TRML
35%
Loosely correlated
+6.71%
VRDN - TRML
34%
Loosely correlated
+5.82%
CRNX - TRML
34%
Loosely correlated
+27.92%
More